Medical Patent News

RSS

Abbott files suit against Watson over generic NIASPAN

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Niacin Extended-release Tablets, 500 mg and 1000 mg. Watson's ANDA products are generic versions of Abbott Laboratories' NIASPAN.

19 Mar 2012

HemCon disappointed with CAFC decision over Marine Polymer patent infringement case

HemCon Medical Technologies, Inc. announced today that the U.S. Court of Appeals for the Federal Circuit (CAFC) issued an en banc decision on March 15, 2012 in the 2006 patent infringement case brought by Marine Polymer Technologies Inc. The decision affirmed a trial court decision awarding damages to Marine Polymer and enjoining the manufacture of infringing products.

17 Mar 2012

USPTO issues patent to iSonea's ultrasound-based cough detector

Medical technology company iSonea Ltd. today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent 2009/0216127 A1 covering its cough count technology in the field of acoustic monitoring of respiratory diseases.

15 Mar 2012

BioLineRx receives European patent for BL-1020 to treat schizophrenia

BioLineRx, a biopharmaceutical development company, announced today that a European patent has been granted claiming BL-1020's composition and its use for the treatment of schizophrenia.

8 Mar 2012

VBC files patent applications related to beneficial health effects of S-ABA

Valent BioSciences Corporation announced today it has filed worldwide patent applications claiming beneficial health effects of abscisic acid (S-ABA) in humans and animals. S-ABA is a naturally occurring substance found in all plants, including fruits and vegetables.

7 Mar 2012

Intellect Neurosciences receives U.S. patent allowance for ANTISENILIN to treat AD

Intellect Neurosciences, Inc., a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases announced today that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent claims covering the company's ANTISENILIN monoclonal antibody platform technology for the treatment and prevention of Alzheimer's disease.

7 Mar 2012

Mylan comments on patent infringement ruling against Sunovion's Brovana

Mylan Inc. today commented on a ruling for partial summary judgment in its patent infringement lawsuit against Sunovion Pharmaceuticals Inc. in relation to Sunovion's Brovana product.

3 Mar 2012

NexGen receives U.S. patent allowance for novel pathogenesis based seizure treatment

NexGen Biomedical, Inc.'s Founder has received a Notice of Allowance from the US Patent Office for a novel treatment method for seizures.

2 Mar 2012

iBio receives U.S. patent for fusion-protein vaccine technology

iBio, Inc. today announced issuance of a US patent covering the use of iBio's proprietary fusion-protein technology in combination with influenza virus antigens for vaccine product applications.

29 Feb 2012

Novartis defends challenge to Indian medicines patent law

Pharmaceutical company Novartis "has spoken out following criticism about its challenge to India's patent laws, insisting that access to life-saving drugs is not under peril by the move," Pharma Times World News reports. The case, which the Indian Supreme Court is scheduled to hear next month, challenges "Indian patent law, notably Section 3(d), which states that a modification of a known chemical composition is non-patentable," the news service writes.

29 Feb 2012

Activists protest Novartis challenge to Indian patent law

In this guest post in the Center for Global Health Policy's "Science Speaks" blog, Brook Baker of the Northeastern University School of Law Program on Human Rights and the Global Economy, "describes and comments on pharmaceutical company Novartis's court challenge to India's strict standards of patenting medicine" and worldwide protests against the company that took place last week prior to its shareholder meeting.

29 Feb 2012

USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI

The International Vaccine Institute (IVI), an international organization based in Seoul devoted to research on the development and introduction of vaccines for the developing world, reached a milestone in its aim to prevent and control dysentery (also commonly called shigellosis or bloody diarrhea), a deadly disease that affects several million people worldwide.

27 Feb 2012

USPTO rejects MonoSol's patent infringement claims against BDSI

The United States Patent & Trademark Office has informed BioDelivery Sciences International, Inc. that it has rejected all claims by MonoSol Rx, LLC (MonoSol) in its US Patent No. 7,425,292 (the '292 Patent) which is currently being asserted against BDSI and its commercial partners for ONSOLIS.

23 Feb 2012

Roche grants in vitro diagnostics product license for real-time PCR technology to LTC

Roche and Life Technologies Corporation announced today that they have entered into two license agreements to allow LTC to expand its PCR offerings for diagnostics applications.

23 Feb 2012

Depomed, Santarus reach agreement to resolve GLUMETZA patent litigation with Lupin

Santarus, Inc. and Depomed, Inc. today announced that they have entered into a settlement agreement with Lupin Ltd. and its subsidiary, Lupin Pharmaceuticals, Inc., to resolve pending patent litigation involving GLUMETZA 1000 mg and 500 mg.

23 Feb 2012

Biotech company defends patent on gene mutation for breast cancer

A US biotechnology company is defending the granting of a controversial patent over a common genetic mutation for breast cancer, rejecting accusations it amounts to the privatization of the human body.

21 Feb 2012

Precision BioSciences sues Cellectis over engineered meganucleases patent infringement

Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that it has filed two patent infringement lawsuits against Cellectis SA and a number of its affiliates in the U.S. District Court for the Eastern District of North Carolina.

21 Feb 2012

ETView Medical enters into patent license agreement for thoracic surgery devices

ETView Medical Ltd. announced today that it has entered into an exclusive license agreement for 2 US patents with James S. Simon, M.D., of Tiburon, California. The licensed patents are U.S. Pat. No. 7,052,456, entitled "Airway products having LEDs", and U.S. Pat. No. 6,189,533, entitled "Endotracheal Intubation Device".

20 Feb 2012

Pfizer, Mylan enter settlement agreement to resolve e-cue patent litigation

Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.

16 Feb 2012

Watson seeks FDA approval to market generic Beyaz

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Drospirenone and Ethinyl Estradiol and Levomefolate Calcium Tablets, 3.0 mg/0.02 mg/0.451 mg and Levomefolate Calcium Tablets, 0.451 mg.

13 Feb 2012

Medical Patent News

Abbott files suit against Watson over generic NIASPAN

HemCon disappointed with CAFC decision over Marine Polymer patent infringement case

USPTO issues patent to iSonea's ultrasound-based cough detector

BioLineRx receives European patent for BL-1020 to treat schizophrenia

VBC files patent applications related to beneficial health effects of S-ABA

Intellect Neurosciences receives U.S. patent allowance for ANTISENILIN to treat AD

Mylan comments on patent infringement ruling against Sunovion's Brovana

NexGen receives U.S. patent allowance for novel pathogenesis based seizure treatment

iBio receives U.S. patent for fusion-protein vaccine technology

Novartis defends challenge to Indian medicines patent law

Activists protest Novartis challenge to Indian patent law

USPTO issues two patents on 'Novel Shigella protein antigens and methods' to IVI

USPTO rejects MonoSol's patent infringement claims against BDSI

Roche grants in vitro diagnostics product license for real-time PCR technology to LTC

Depomed, Santarus reach agreement to resolve GLUMETZA patent litigation with Lupin

Biotech company defends patent on gene mutation for breast cancer

Precision BioSciences sues Cellectis over engineered meganucleases patent infringement

ETView Medical enters into patent license agreement for thoracic surgery devices

Pfizer, Mylan enter settlement agreement to resolve e-cue patent litigation

Watson seeks FDA approval to market generic Beyaz

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News